Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.

Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.

Item
http://www.wikidata.org/entity/Q30430626
Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutininA combination of DNA vaccines targeting human papillomavirus type 16 E6 and E7 generates potent antitumor effectsRecombinant lambda-phage nanobioparticles for tumor therapy in mice models.Dendritic cell-mediated, DNA-based vaccination against hepatitis C induces the multi-epitope-specific response of humanized, HLA transgenic mice.Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγImmunogenicity in mice and rhesus monkeys vaccinated with recombinant vaccinia virus expressing bivalent E7E6 fusion proteins from human papillomavirus types 16 and 18.Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen.Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques.Rejection of large HPV-16 expressing tumors in aged mice by a single immunization of VacciMax encapsulated CTL/T helper peptides.A DNA vaccine encoding mutated HPV58 mE6E7-Fc-GPI fusion antigen and GM-CSF and B7.1.Virus-Like Particles Harboring CCL19, IL-2 and HPV16 E7 Elicit Protective T Cell Responses in HLA-A2 Transgenic MiceCytolytic activity of the human papillomavirus type 16 E711-20 epitope-specific cytotoxic T lymphocyte is enhanced by heat shock protein 110 in HLA-A*0201 transgenic mice.Recent advances in strategies for immunotherapy of human papillomavirus-induced lesions.Identification of the murine H-2D(b) and human HLA-A*0201 MHC class I-restricted HPV6 E7-specific cytotoxic T lymphocyte epitopes.Development of chimeric candidate vaccine against HPV18: a proof of concept.Enhanced antitumor immunotherapeutic effect of B-cell-based vaccine transduced with modified adenoviral vector containing type 35 fiber structures.Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DOβ as a novel target for multiple myeloma
P2860

Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.

Item
http://www.wikidata.org/entity/Q30430626
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Characterization of HLA-A2-res ...... nes in HLA-A2 transgenic mice.
@ast
Characterization of HLA-A2-res ...... nes in HLA-A2 transgenic mice.
@en
type
label
Characterization of HLA-A2-res ...... nes in HLA-A2 transgenic mice.
@ast
Characterization of HLA-A2-res ...... nes in HLA-A2 transgenic mice.
@en
prefLabel
Characterization of HLA-A2-res ...... nes in HLA-A2 transgenic mice.
@ast
Characterization of HLA-A2-res ...... nes in HLA-A2 transgenic mice.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Characterization of HLA-A2-res ...... nes in HLA-A2 transgenic mice.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P932